Autoinjectors Market to grow at a Significant Rate During the Forecast Period
Availability of generic versions of autoinjectors is
driving the growth of Global Autoinjectors Market in the forecast years,
2022-2026.
According to TechSci
Research report, “Global Autoinjectors Market By Therapy (Rheumatoid
Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others) By Design
(Standardized v/s Customized) By Product (Prefilled v/s Fillable) By Technology
(Automated v/s Manual) By Type (Disposable v/s Reusable) By Route of
Administration (Intravenous v/s Subcutaneous) By End User (Hospitals &
Clinics, Ambulatory Care Settings, Home Care Settings) By Region, Competition
Forecast & Opportunities, 2026”, the global
autoinjectors market is expected to show a double digit CAGR growth in thee
upcoming five years, 2022-2026. The market is expected to show the growth owing
to the undeniable factors like increasing cases of anaphylaxis and population
developing allergies out of various things. The changing lifestyles and life
choices has rendered the immune system of the world population at risk. This
has resulted in development of various allergies among the population.
Moreover, rising demand of epinephrine autoinjectors and demand for adrenaline
injectors among the sports personnel is driving the growth of the market.
Autoinjector is a
medical device that delivers the drug in the system and does not require a
professional to do so. It is a self-administrating kind of injection which is
needle-less and is often administered in thighs or buttocks. The autoinjectors
are often applied in case of rheumatoid arthritis, multiple sclerosis,
diabetes, anaphylaxis, etc. Technological advances like accuracy, better
efficiency, lower probability of needle-stick injuries and complications,
consistent dosage delivery, simplicity and safety are prevailing the preference
of the device among the population, thereby driving the growth of global
autoinjectors market, positively in upcoming five years.
Browse over XX market data Figures spread through 110 Pages
and an in-depth TOC on "Global Autoinjectors Market"
https://www.techsciresearch.com/report/autoinjectors-market/7341.html
The global autoinjector
market is segmented by therapy, design, product, technology, type, route of
administration, end user, regional distribution, and competitional landscape.
Based on type the market is divided between disposable and reusable
autoinjectors. Since disposable autoinjectors are easier to use, more
convenient, and is often according to the patient’s preference, it holds the
larger market share as compared to reusable autoinjectors. Based on product,
the market is categorized into prefilled or fillable autoinjectors. These are
majorly types of reusable autoinjectors and prefilled reusable autoinjector
holds the larger market among the two. The dominance in the market is owed to
factors like standard prefilled barrels containing therapeutic drugs. Prefilled
autoinjectors eradicates the chances of any human error while measuring the
drug dosage and thus is preferred.
Some
of the major competitors in the market are Abaxis Inc., BioMerieux SA, Idexx
Laboratories Corporation, Heska Corporation, Virbac SA, Zoetis Inc., Woodley
Veterinary Diagnostics Ltd., Randox Laboratories Ltd., Neogen Corporation,
Thermo Fisher Scientific Inc., among others. The companies are focusing on
extensive research and developments activities to stay competitive in the
market. Other competitive strategies include formation of alliances and
partnerships.
Download Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=7341
Customers can also request for 10% free customization on this report.
“Home care end users are potentially holding fastest market share growth
in the next five years. Rising adoption of medical devices that are easily
accessible and demonstrates easier user interface among the home care systems
is going to be a major growth factor for the future market. Growing geriatric
population and increasing instances of diabetes among the population is
inviting more self-administered dosage of drugs thereby promoting the idea of
autoinjectors. Patients with fear of needles benefit most out of the
autoinjectors that are available needle less. With best medical and health
facilities, North American region is expected to hold the largest market share.
Whereas Asia Pacific could be the fastest growing market owing to its
increasing diabetic patient count, rising cases of anaphylaxis, in Asian
countries like China, Japan, India, South Korea, etc. New players might benefit
with the increased awareness drives regarding the usage and advantages of the
autoinjector devices,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based Global management consulting firm.
“Global Autoinjectors
Market By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes,
Anaphylaxis, Others) By Design (Standardized v/s Customized) By Product
(Prefilled v/s Fillable) By Technology (Automated v/s Manual) By Type
(Disposable v/s Reusable) By Route of Administration (Intravenous v/s
Subcutaneous) By End User (Hospitals & Clinics, Ambulatory Care Settings,
Home Care Settings) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential
of Global Autoinjectors and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Autoinjectors.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/